Norges Bank
REGN icon

Norges Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$628M Buy
+1,196,479
New +$628M 0.08% 235
2025
Q1
Sell
-1,125,933
Closed -$802M 1296
2024
Q4
$802M Buy
+1,125,933
New +$802M 0.11% 177
2024
Q3
Sell
-1,126,948
Closed -$1.18B 1358
2024
Q2
$1.18B Buy
1,126,948
+22,674
+2% +$23.8M 0.18% 104
2024
Q1
$1.06B Buy
1,104,274
+42,471
+4% +$40.9M 0.17% 120
2023
Q4
$933M Buy
1,061,803
+3,051
+0.3% +$2.68M 0.16% 128
2023
Q3
$871M Buy
1,058,752
+12,397
+1% +$10.2M 0.18% 118
2023
Q2
$752M Buy
1,046,355
+45,242
+5% +$32.5M 0.15% 133
2023
Q1
$823M Buy
1,001,113
+34,646
+4% +$28.5M 0.18% 111
2022
Q4
$697M Buy
966,467
+59,854
+7% +$43.2M 0.17% 124
2022
Q3
$625M Buy
906,613
+24,303
+3% +$16.7M 0.17% 114
2022
Q2
$522M Sell
882,310
-105,326
-11% -$62.3M 0.13% 153
2022
Q1
$690M Buy
987,636
+22,945
+2% +$16M 0.15% 129
2021
Q4
$609M Sell
964,691
-15,695
-2% -$9.91M 0.13% 151
2021
Q3
$593M Sell
980,386
-56,321
-5% -$34.1M 0.13% 150
2021
Q2
$579M Buy
1,036,707
+56,299
+6% +$31.4M 0.13% 161
2021
Q1
$464M Sell
980,408
-68,709
-7% -$32.5M 0.11% 184
2020
Q4
$507M Sell
1,049,117
-122,982
-10% -$59.4M 0.12% 166
2020
Q3
$656M Sell
1,172,099
-81,428
-6% -$45.6M 0.17% 107
2020
Q2
$782M Buy
1,253,527
+433,272
+53% +$270M 0.23% 75
2020
Q1
$401M Buy
820,255
+3,375
+0.4% +$1.65M 0.14% 140
2019
Q4
$307M Hold
816,880
0.09% 220
2019
Q3
$227M Hold
816,880
0.07% 268
2019
Q2
$256M Buy
816,880
+16,098
+2% +$5.04M 0.08% 246
2019
Q1
$329M Buy
800,782
+17,765
+2% +$7.29M 0.11% 182
2018
Q4
$292M Hold
783,017
0.11% 185
2018
Q3
$316M Sell
783,017
-47,021
-6% -$19M 0.1% 184
2018
Q2
$286M Buy
830,038
+5,079
+0.6% +$1.75M 0.1% 209
2018
Q1
$284M Buy
824,959
+29,491
+4% +$10.2M 0.1% 195
2017
Q4
$299M Buy
795,468
+38,756
+5% +$14.6M 0.11% 192
2017
Q3
$338M Sell
756,712
-19,657
-3% -$8.79M 0.13% 163
2017
Q2
$381M Sell
776,369
-8,024
-1% -$3.94M 0.15% 131
2017
Q1
$304M Sell
784,393
-9,850
-1% -$3.82M 0.12% 164
2016
Q4
$292M Sell
794,243
-1,291
-0.2% -$474K 0.13% 164
2016
Q3
$305M Buy
795,534
+83,194
+12% +$31.9M 0.14% 132
2016
Q2
$249M Buy
712,340
+13,745
+2% +$4.8M 0.12% 171
2016
Q1
$252M Sell
698,595
-15,499
-2% -$5.59M 0.12% 160
2015
Q4
$388M Sell
714,094
-37,296
-5% -$20.2M 0.19% 102
2015
Q3
$350M Buy
751,390
+14,939
+2% +$6.95M 0.18% 107
2015
Q2
$376M Buy
736,451
+18,748
+3% +$9.56M 0.19% 107
2015
Q1
$324M Buy
717,703
+28,635
+4% +$12.9M 0.16% 126
2014
Q4
$283M Buy
689,068
+16,645
+2% +$6.83M 0.14% 135
2014
Q3
$242M Sell
672,423
-622,423
-48% -$224M 0.13% 149
2014
Q2
$366M Buy
1,294,846
+652,285
+102% +$184M 0.1% 203
2014
Q1
$193M Buy
642,561
+9,148
+1% +$2.75M 0.11% 184
2013
Q4
$174M Sell
633,413
-55,619
-8% -$15.3M 0.1% 200
2013
Q3
$216M Buy
689,032
+42,596
+7% +$13.3M 0.13% 158
2013
Q2
$145M Buy
+646,436
New +$145M 0.09% 224